UPDATE: Credit Suisse Upgrades BioMarin Pharmaceutical

By: via Benzinga
In a note released Monday morning a team of analysts at Credit Suisse updated shares of BioMarin Pharmaceutical (NASDAQ: BMRN) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.